Opioid Use Disorder Market Projected to Surpass USD 8.1 Billion by 2031

According to the report published by Allied Market Research, the global opioids use disorder market was estimated at $2.8 billion in 2021 and is expected to hit $8.1 billion by 2031, registering a CAGR of 11.5% from 2022 to 2031.

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭
https://www.alliedmarketresearch.com/request-sample/12668

𝐂𝐨𝐯𝐢𝐝-19 𝐬𝐜𝐞𝐧𝐚𝐫𝐢𝐨-
A huge number of clinics, hospitals across the globe, were restructured to increase the hospital capacity for the patients diagnosed with Covid-19. Moreover, the postponement or cancellation of doctor appointments affected the global opioids use disorder market severely.
Drop in the number of scheduled surgeries led to decline in demand for opioids which cause decrease in the prevalence of opioid use disorder.

The global opioids use disorder market is analyzed across drug type, age group, route of administration, distribution channel, and region. The report takes in an exhaustive analysis of segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.

Based on drug type, the agonist segment contributed to more than four-fifths of the global opioids use disorder market in 2021 and is expected to dominate by 2031. The same segment would also showcase the fastest CAGR of 11.6% throughout the forecast period.

Based on age group, the 19 to 39 segment held nearly half of the total market revenue in 2021 and is expected to dominate by 2031. The same segment would also manifest the fastest CAGR of 11.9% throughout the forecast period.

Based on route of administration, the intravenous segment held around more than half of the total market revenue in 2021 and is expected to dominate by 2031. The same segment would also cite the fastest CAGR of 11.9% throughout the forecast period.

By distribution channel, the hospital pharmacy segment held nearly three-fourths of the total market revenue in 2021 and is expected to dominate by 2031. The same segment would also project the fastest CAGR of 11.6% throughout the forecast period.

Based on region, the market across North America generated nearly two-fifths of the global opioids use disorder market revenue in 2021 and is anticipated to retain the lion's share by 2031. Asia-Pacific, on the other hand, would showcase the fastest CAGR of 12.3% during the forecast period. The other regions studied in the report include LAMEA and Europe.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲- https://www.alliedmarketresearch.com/purchase-enquiry/12668

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
Braeburn Pharmaceuticals
Orexo AB (mentioned twice; please confirm if it's intentional)
Hikma Pharmaceuticals PLC
Alkermes, Inc.
Reckitt Benckiser Pharmaceuticals Inc
Indivior PLC
BioDelivery Sciences International Inc.
Mallinckrodt Pharmaceuticals
Dr. Reddy's Laboratories Ltd
Sandoz
AstraZeneca plc
Titan Pharmaceuticals, Inc.
Pear Therapeutics
NYC Health Hospitals
Viatris Inc
Camurus

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐎𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲
• By type, the agonist segment was the highest contributor to the market in 2021.
• By age group, the 19 to 39 segment was the highest contributor to the market in 2021.
• By route of administration, the intravenous segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
• By distribution channel, the hospital pharmacy segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
• By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞 https://www.alliedmarketresearch.com/opioid-use-disorder-market-A12303

𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲-
𝑪𝒍𝒆𝒂𝒏𝒓𝒐𝒐𝒎 𝑪𝒐𝒏𝒔𝒖𝒎𝒂𝒃𝒍𝒆𝒔 𝒎𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/cleanroom-consumables-market-A10926

𝑭𝒆𝒕𝒂𝒍 𝑩𝒐𝒗𝒊𝒏𝒆 𝑺𝒆𝒓𝒖𝒎 𝑴𝒂𝒓𝒌𝒆𝒕 https://www.alliedmarketresearch.com/fetal-bovine-serum-market

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.